A New York jury found former President Donald Trump guilty on 34 felony counts of falsifying business records to cover…
Read More »
As the tobacco industry faces increasing regulatory scrutiny and changing consumer preferences, the major players are pivoting towards reduced-risk nicotine…
Read More »
ELEVAI Labs (NASDAQ: ELAB), a pioneering force in medical aesthetics, announced that Chief Executive Officer Jordan R. Plews, PhD has…
Read More »
In a groundbreaking move, Donald J. Trump’s 2024 presidential campaign has announced it will accept cryptocurrency donations, marking the first…
Read More »
The recent approval by the U.S. Securities and Exchange Commission (SEC) of spot Ethereum (ETHUSD) exchange-traded funds (ETFs) marks a…
Read More »
ELEVAI Labs (NASDAQ: ELAB), a pioneering force in medical aesthetics, announced that Chief Executive Officer Dr. Jordan R. Plews, PhD…
Read More »
ELEVAI Labs (NASDAQ: ELAB), a pioneering force in medical aesthetics, reported its financial results for the first quarter ended March…
Read More »
ELEVAI Labs (NASDAQ: ELAB), a pioneering force in medical aesthetics, has made significant strides of late with the launch of…
Read More »
ELEVAI Labs established two subsidiaries: ELEVAI Biosciences, Inc., and ELEVAI Skincare, Inc. ELEVAI Biosciences will focus on acquiring and developing…
Read More »
The agreement adds two drug candidates to the company’s product pipeline, “EL-22”, a clinical-stage engineered probiotic expressing myostatin, and “EL-32”,…
Read More »